{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:46:58Z","timestamp":1770450418991,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijpharm.2017.06.047","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:01:42Z","timestamp":1497571302000},"page":"395-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Optimisation of HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeutics"],"prefix":"10.1016","volume":"528","author":[{"given":"Arnout","family":"Everaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Melsbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Kiekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Weyenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.047_bib0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1208\/s12249-011-9701-3","article-title":"Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro\/in vivo evaluation","volume":"12","author":"Aburahma","year":"2011","journal-title":"AAPS Pharm. Sci. Technol."},{"issue":"11","key":"10.1016\/j.ijpharm.2017.06.047_bib0010","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(97)00212-5","article-title":"Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections","volume":"52","author":"Baeyens","year":"1998","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.047_bib0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/13543780902855316","article-title":"VEGF inhibitors for the treatment of neovascular age-related macular degeneration","volume":"15","author":"Barakat","year":"2009","journal-title":"Exp. Opin. Inv. Drug."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0168-3659(00)00366-7","article-title":"Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate","volume":"70","author":"Bettini","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0030","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/protein\/10.10.1235","article-title":"The self catalytic enzyme inactivation induced by solvent stirring: a new example of protein conformational change induction","volume":"10","author":"Caussette","year":"1997","journal-title":"Protein Eng."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.047_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.047_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0141-0229(81)90068-5","article-title":"Shear effects on enzymes","volume":"3","author":"Charm","year":"1981","journal-title":"Enzyme Microb. Technol."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1005655005780","article-title":"Stirring effect on lysozyme inactivation and aggregation: kinetic study and aggregates characterisation","volume":"22","author":"Colombi\u00e9","year":"2000","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1440-1681.2000.03288.x","article-title":"Biopharmaceutical considerations in topical ocular drug delivery","volume":"27","author":"Davies","year":"2000","journal-title":"Clin. Exp. Pharmacol. P."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.047_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2010.07.002","article-title":"The effect of shear stress on protein conformation: physical forces operating on biochemical systems: the case of von Willebrand factor","volume":"153","author":"Di Stasio","year":"2010","journal-title":"Biophys. Chem."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.047_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.survophthal.2004.12.006","article-title":"Applications of liposomes in ophthalmology","volume":"50","author":"Ebrahim","year":"2005","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ijpharm.2017.06.047_bib0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.preteyeres.2010.04.001","article-title":"Protein delivery for retinal diseases: from basic considerations to clinical applications","volume":"29","author":"El Sanharawi","year":"2010","journal-title":"Progr. Retinal Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2017.06.047_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2015.01.042","article-title":"Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeutics","volume":"481","author":"Everaert","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.047_bib0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijpharm.2014.02.028","article-title":"Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices","volume":"465","author":"Ghori","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.047_bib0085","first-page":"147","article-title":"Mathematical modeling of drug release profiles for modified hydrophobic HPMC based gels","volume":"67","author":"Ghosal","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0090","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/aic.690320717","article-title":"The formation and growth of protein precipitates in a continuous stirred-tank reactor","volume":"32","author":"Glatz","year":"1986","journal-title":"AIChE J."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0095","doi-asserted-by":"crossref","first-page":"c4976","DOI":"10.1136\/bmj.c4976","article-title":"Investigation and management of uveitis","volume":"341","author":"Guly","year":"2010","journal-title":"BMJ"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2017.06.047_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2014.06.017","article-title":"Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A","volume":"472","author":"Hermans","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0105","first-page":"2143","article-title":"Intermolecular forces in the process of heat aggregation of globular proteins and the problem of correlation between aggregation and denaturation phenomena","volume":"16","author":"Jaenicke","year":"1967","journal-title":"J. Polym. Sci."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.047_bib0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","article-title":"Ocular preparations: the formulation approach","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.047_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-409X(95)00012-V","article-title":"Ocular drug delivery conventional ocular formulations","volume":"16","author":"Lang","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"4\u20135","key":"10.1016\/j.ijpharm.2017.06.047_bib0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/15216540051081056","article-title":"Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation","volume":"50","author":"Levine","year":"2000","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0130","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.06.047_bib0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0142-9418(98)00052-X","article-title":"Diffusion of water through various polymer films: a new high performance method of characterization","volume":"18","author":"M\u00e9tayer","year":"1999","journal-title":"Polym. Test."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0290(19960820)51:4<458::AID-BIT9>3.0.CO;2-H","article-title":"Effect of high shear on proteins","volume":"51","author":"Maa","year":"1996","journal-title":"Biotechnol. Bioeng."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.047_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02853166","article-title":"Effects of common ophthalmic preservatives on ocular health","volume":"18","author":"Noecker","year":"2001","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.047_bib0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.ICL.0000141921.80061.17","article-title":"Ocular surface temperature: a review","volume":"31","author":"Purslow","year":"2005","journal-title":"Eye Contact Lens."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-3659(94)00016-6","article-title":"Structure and behaviour in hydrophilic matrix sustained release dosage forms: 2: NMR-imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration","volume":"31","author":"Rajabi-Siahboomi","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II: Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","article-title":"Ocular inserts for topical delivery","volume":"16","author":"Saettone","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/jop.1990.6.243","article-title":"Review: systemic absorption of topically applied ocular drugs in humans","volume":"6","author":"Salminen","year":"1990","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0175","first-page":"1","article-title":"Solvent cast technology \u2013 a versatile tool for thin film production","volume":"130","author":"Siemann","year":"2005","journal-title":"Prog. Colloid Polym. Sci."},{"issue":"11","key":"10.1016\/j.ijpharm.2017.06.047_bib0180","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1023\/A:1018914301328","article-title":"HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics","volume":"16","author":"Siepmann","year":"1999","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ijpharm.2017.06.047_bib0185","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/17425247.2014.927864","article-title":"Intravitreal drug delivery in retinal disease: are we out of our depth?","volume":"11","author":"Thakur","year":"2014","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0190","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/bit.260211209","article-title":"Action of shear on enzymes: studies with catalase and urease","volume":"21","author":"Thomas","year":"1979","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.047_bib0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11095-013-1199-9","article-title":"Oxidation of therapeutic proteins and peptides: structural and biological consequences","volume":"31","author":"Torosantucci","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1097-0290(19980805)59:3<273::AID-BIT2>3.0.CO;2-8","article-title":"Study of protein aggregation due to heat denaturation: a structural approach using circular dichroism spectroscopy, nuclear magnetic resonance, and static light scattering","volume":"59","author":"Tsai","year":"1998","journal-title":"Biotechnol. Bioeng."},{"issue":"6","key":"10.1016\/j.ijpharm.2017.06.047_bib0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","article-title":"Minimizing systemic absorption of topically administered ophthalmic drugs","volume":"37","author":"Urtti","year":"1993","journal-title":"Surv. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.047_bib0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2015.961420","article-title":"Long-term delivery of protein therapeutics","volume":"12","author":"Vaishya","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.047_bib0215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10570-007-9182-4","article-title":"Study of cell behaviour on a cellulose anti-adhesive substratum","volume":"15","author":"Velzenberger","year":"2008","journal-title":"Cellulose"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/bit.260230216","article-title":"Studies of the effect of shear on globular proteins: extension to high shear fields and to pumps","volume":"23","author":"Virkar","year":"1981","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0891-5849(94)00158-G","article-title":"Oxidation of methionyl residues in proteins Tools, targets, and reversal","volume":"18","author":"Vogt","year":"1995","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.047_bib0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clae.2007.09.002","article-title":"Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review","volume":"31","author":"Xinming","year":"2008","journal-title":"Cont. Lens Anterior Eye"},{"key":"10.1016\/j.ijpharm.2017.06.047_bib0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","article-title":"Microspheres and nanoparticles used in ocular delivery systems","volume":"16","author":"Zimmer","year":"1995","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T17:28:00Z","timestamp":1535736480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317305550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0378517317305550"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.047","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimisation of HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeutics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}